The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

GlaxoSmithKline PLC

NYSE: GSK
Last

(U.S.) $43.74

Today's change-0.16 -0.36%
Updated August 25 4:02 PM EDT. Delayed by at least 15 minutes.
 

GlaxoSmithKline PLC

NYSE: GSK
Last

(U.S.) $43.74

Today's change-0.16 -0.36%
Updated August 25 4:02 PM EDT. Delayed by at least 15 minutes.

GlaxoSmithKline PLC down (U.S.)$0.16

GlaxoSmithKline PLC closed lower Thursday, dropping (U.S.)$0.16 or 0.36% to (U.S.)$43.74. Shares have lost 1.69% over the last five days, but sit 4.04% below their 52-week high. This security has underperformed the S&P 500 by 5.34% during the last year.

Key company metrics

  • Open(U.S.) $44.00
  • Previous close(U.S.) $43.90
  • High(U.S.) $44.10
  • Low(U.S.) $43.65
  • Bid / Ask(U.S.) $43.04 / (U.S.) $44.58
  • YTD % change+8.40%
  • Volume2,259,901
  • Average volume (10-day)2,112,047
  • Average volume (1-month)2,719,550
  • Average volume (3-month)3,238,556
  • 52-week range(U.S.) $37.24 to (U.S.) $45.58
  • Beta0.84
  • Trailing P/E3,146.76×
  • P/E 1 year forward16.87×
  • Forward PEG1.69×
  • Indicated annual dividend(U.S.) $2.20
  • Dividend yield5.04%
  • Trailing EPS(U.S.) $0.01
Updated August 25 4:02 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue6,5326,2296,2866,127
Total other revenue--------
Total revenue6,5326,2296,2866,127
Gross profit4,4764,1594,0824,061
Total cost of revenue2,0562,0702,2042,066
Total operating expense6,6835,5066,5395,104
Selling / general / administrative2,0752,0762,1221,914
Research & development800775846730
Depreciation / amortization1010109
Interest expense (income), net operating--------
Unusual expense (income)1,825666910282
Other operating expenses, total-83-91447103
Operating income-151723-2531,023
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-318560-416867
Income after tax-492352-428647
Income tax, total17420812220
Net income-435282-354538
Total adjustments to net income--------
Net income before extra. items-435282-354538
Minority interest57-7074-109
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-435282-354538
Inc. avail. to common incl. extra. items-435282-354538
Diluted net income-435282-354538
Dilution adjustment--000
Diluted weighted average shares4,8594,8904,8374,877
Diluted EPS excluding extraordinary itemsvalue per share-0.090.06-0.070.11
Dividends per sharevalue per share0.190.190.230.19
Diluted normalized EPSvalue per share0.150.140.050.15